¿¬¼ö°­ÁÂ
´ëÇѺñ´¢±âÁ¾¾çÇÐȸ The 22nd KUOS Multidisciplinary Conference(1ÀÏÂ÷) : 2024-03-22

´ëÇѺñ´¢±âÁ¾¾çÇÐȸ The 22nd KUOS Multidisciplinary Conference(1ÀÏÂ÷) : 2024-03-22
±³À°ÀÏÀÚ : 2024-03-22
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : The 22nd KUOS Multidisciplinary Conference(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574  

À̸ÞÀÏ : app@app2010.com

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 30,000¿ø  

ºñ°í Àü¹®ÀÇ: 30,000¿ø / Àü°øÀÇ, ±ºÀÇ°ü, °£È£»ç: 20,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 13:40~14:00 1. Update of pelvic lymph node dissection in prostate and bladder cancer À¯¼ºÇö(Àü³²ÀÇ´ë ºñ´¢ÀÇÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:00~14:20 2. Update in systemic treatment in genitourinary cancer ±èÀÎÈ£(°¡Å縯ÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:20~14:40 3. Heavy ion radiotherapy: initial experience ÀÌÀÍÀç(¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:40~14:50 Q&A ()

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:50~15:03 (±¸¿¬) 1. Role of radical prostatectomy in elderly patients °­¼º±¸(°í·ÁÀÇ´ë ºñ´¢ÀÇÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:03~15:16 (±¸¿¬) 2. Non-surgical treatment for localized prostate cancer in elderly patients ±èÇöÁÖ(°¡ÃµÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:16~15:30 (±¸¿¬) 3. Management of complications after definitivie radiotherapy for prostate cancer ÀÓ¹üÁø(¿ï»êÀÇ´ë ºñ´¢ÀÇÇаú)

½Ä»ç 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:30~15:50 Break ()

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:50~16:20 Understanding the Role of Genetic Ancestry in Prostate Cancer Health Disparities Vanessa Hayes(University of Sydney)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 16:20~16:33 (±¸¿¬) 1. Radiologic features of non-clear cell RCC ¹Ú°èÁø(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 16:33~16:46 (±¸¿¬) 2. Genomic features of non-clear cell RCC ¹ÚÀαÙ(¿ï»êÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 16:46~17:00 (±¸¿¬) 3. Guideline updates for the mangement of metastatic non-clear cell RCC ¹ÚÀ翵(°í·ÁÀÇ´ë ºñ´¢ÀÇÇаú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 17:00~17:20 (±¸¿¬) 1. Ureter recurrence after radical cystectomy ±è¾îÁø(¼º±Õ°üÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ¼¼Á¾´ëÇб³ ±¤°³Åä°ü ÁöÇÏ2Ãþ ÄÁº¥¼Ç¼¾ÅÍ 17:20~17:40 (±¸¿¬) 2. Synchronous urothelial carcinoma of bilateral ureters and bladder. º¯»óÁØ(°è¸íÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,085 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,055 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,097 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,184 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,786 , ´ñ±Û¼ö : 0